Elucidating the Efficacy of the Bacille Calmette–Guérin Vaccination in Conjunction with First Line Antibiotics and Liposomal Glutathione
Authors:
- Rachel AbrahemRARachel Abrahem
- Ruoqiong CaoRCRuoqiong Cao
- Brittanie RobinsonBRBrittanie Robinson
- Shalok MunjalSMShalok Munjal
- Thomas ChoTCThomas Cho
- Kimberly ToKTKimberly To
- David AshleyDADavid Ashley
- Joshua HernandezJHJoshua Hernandez
- Timothy NguyenTNTimothy Nguyen
- Garrett TeskeyGTGarrett Teskey
- Vishwanath VenketaramanVishwanath Venketaraman
Open Access
- 27 September 2019
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (10) , 1556
Abstract
Mycobacterium tuberculosis (M. tb) is the etiological agent that is responsible for causing tuberculosis (TB). Although every year M. tb infection affects millions of people worldwide, the only vaccine that is currently available is the Bacille Calmette–Guérin (BCG) vaccine. However, the BCG vaccine has varying efficacy. Additionally, the first line antibiotics administered to patients with active TB often cause severe complications and side effects. To improve upon the host response mechanism in containing M. tb infection, our lab has previously shown that the addition of the biological antioxidant glutathione (GSH) has profound antimycobacterial effects. The aim of this study is to understand the additive effects of BCG vaccination and ex-vivo GSH enhancement in improving the immune responses against M. tb in both groups; specifically, their ability to mount an effective immune response against M. tb infection, maintain CD4+ and CD8+ T cells in the granulomas, their response to liposomal glutathione (L-GSH), with varying suboptimal levels of the first line antibiotics isoniazid (INH) and pyrazinamide (PZA), the expressions of programmed death receptor 1 (PD-1), and their ability to induce autophagy. Our results revealed that BCG vaccination, along with GSH enhancement, can prevent the loss of CD4+ and CD8+ T cells in the granulomas and improve the control of M. tb infection by decreasing the expressions of PD-1 and increasing autophagy and production of the cytokines interferon gamma IFN-γ and tumor necrosis factor-α (TNF-α).Keywords
This publication has 26 references indexed in Scilit:
- In vivo inhibition of tryptophan catabolism reorganizes the tuberculoma and augments immune-mediated control ofMycobacterium tuberculosisProceedings of the National Academy of Sciences, 2017
- Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytesJournal of Autoimmunity, 2014
- Modeling the Mycobacterium tuberculosis Granuloma – the Critical Battlefield in Host Immunity and DiseaseFrontiers in Immunology, 2013
- Virulence factors of theMycobacterium tuberculosiscomplexVirulence, 2013
- Discovery and Development of SQ109: A New Antitubercular Drug with a Novel Mechanism of ActionFuture Microbiology, 2012
- Revisiting the role of the granuloma in tuberculosisNature Reviews Immunology, 2012
- Role of innate cytokines in mycobacterial infectionMucosal Immunology, 2011
- Foamy macrophages and the progression of the human tuberculosis granulomaNature Immunology, 2009
- Innate Immunity toMycobacterium tuberculosisClinical Microbiology Reviews, 2002
- Immunology of TuberculosisAnnual Review of Immunology, 2001